In this issue:
Fetal and neonatal adverse drug reactions associated with biologics
Olokizumab + methotrexate for RA
JIA treated with etanercept biosimilar
Rituximab worsens COVID-19 outcomes in RA
Anti-TNF vs tocilizumab for refractory Behcet's uveitic cystoid macular oedema
Tocilizumab in adult-onset Still's disease
Anti-oncostatin M monoclonal antibody in systemic sclerosis
Biologics for relapsing and/or refractory polyarteritis nodosa
Direct and indirect effects of anifrolumab on patient-reported outcomes
Obinutuzumab for SLE with secondary non-response to rituximab
Impact of PsA and comorbidities on ustekinumab outcomes in psoriasis
Discontinuation of biologic therapy in RA and AS
Please login below to download this issue (PDF)